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An extract from whole oocytes of Xenopus laevis was shown to transcribe somatic-type 5S RNA genes
-100-fold more efficiently than oocyte-type 5S RNA genes. This preference was at least 10-fold greater than the
preference seen upon microinjection of 5S RNA genes into oocyte nuclei or upon in vitro transcription in an
oocyte nuclear extract. The - 100-fold transcriptional bias in favor of the somatic-type 5S RNA genes observed
in vitro in the whole oocyte extract was similar to the transcriptional bias observed in developing Xenopus
embryos. We also showed that in the whole oocyte extract, a promoter-binding protein required for 5S RNA
gene transcription, TFIHA, was bound both to the actively transcribed somatic-type 5S RNA genes and to the
largely inactive oocyte-type 5S RNA genes. These findings suggest that the mechanism for the differential
expression of 5S RNA genes during Xenopus development does not involve differential binding of TFIIIA to 5S
RNA genes.
The genome of the frog Xenopus laevis contains two
distinct families of genes for 5S RNA, the smallest RNA
component of the ribosome. In the developing oocyte of this
amphibian, genomic 5S RNA genes of both families are
actively transcribed, yielding large amounts of stored 5S
RNA for subsequent ribosome production during embryo-
genesis. The oocyte-type family of 5S RNA genes, with
approximately 20,000 copies per haploid genome, is tran-
scribed during oogenesis but is relatively inactive during
embryogenesis and is switched off in somatic cells. In
contrast, the somatic-type family of 5S RNA genes, with
approximately 400 copies per haploid genome, is transcribed
during both oogenesis and embryogenesis and is also active
in somatic cells. Transcription of Xenopus 5S RNA genes
has been extensively studied both in vitro and in vivo, in part
because these genes provide a well-defined example of
differential regulation of gene expression during develop-
ment (5, 6, 16).
Like other genes transcribed by RNA polymerase III,
such as the tRNA genes, 5S RNA genes require factors
TFIIIB and TFIIIC for transcription (26, 29). Unlike the
tRNA genes, however, transcription of 5S RNA genes
requires an additional factor, TFIIIA (8). This protein has
been purified to homogeneity and extensively studied (1, 11,
23). The first step in the kinetic pathway for the transcription
of 5S RNA genes involves the binding of TFIIIA to the
internal control region within the 120-base-pair SS RNA
coding sequence. The mode of DNA binding by TFIIIA is
thought to involve multiple Zn2'-stabilized domains of
TFIIIA, each of the domains interacting with a specific
stretch of DNA approximately 5 base pairs long (21). After
formation of a complex between TFIIIA and the 5S RNA
gene, the other transcription factors, TFIIIC and TFIIIB,
can bind in turn, forming a stable transcription complex
which in the presence of RNA polymerase III is capable of
directing multiple rounds of transcription of the 5S RNA
gene (4, 18, 27).
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Whereas the nucleotide sequences flanking the oocyte-
type and somatic-type 5S RNA genes are strikingly different
from each other, the corresponding coding sequences differ
in only a few positions out of the 120 base pairs (see Fig. 1).
So far, no functional differences have been detected between
the oocyte-type and somatic-type 5S RNAs. The few nucle-
otide sequence differences between the coding regions of the
corresponding genes are sufficient, however, to result in
slightly different affinities of TFIIIA for the two types of 5S
RNA genes (24, 33). The approximately fivefold greater
affinity of TFIIIA for somatic over oocyte 5S RNA genes is
the basis for current models of the differential expression of
these two gene families during development. The models
invoke mechanisms to amplify this difference in binding
affinity observed in vitro such that the ratio of TFIIIA
actually bound to the two types of 5S RNA genes in vivo
would reflect the ratio of their observed transcription rates
(4, 7, 9, 13, 25). One implicit assumption in these models is
that 5S RNA genes with bound TFIIIA will be actively
transcribed in an environment that supplies all other neces-
sary components of the transcription complex.
The results of the present work indicate that binding of
TFIIIA to an oocyte 5S RNA gene is not always sufficient to
activate transcription of that gene even in the presence of all
of the components necessary for transcription of 5S RNA
genes. Specifically, under in vitro transcription conditions,
in which somatic 5S RNA genes are transcribed but oocyte
5S RNA genes are largely inactive, we show that TFIIIA is
bound to the internal control regions of both genes. This
result implies that the differential expression of 5S RNA
genes is not directly controlled by the relative occupancy of
the internal control regions of these genes with TFIIIA.
MATERIALS AND METHODS
Plasmid constructions. All inserts were cloned either into
the HindIll site or between the Hindlll and EcoRI sites of
the vector pJW1+4. This vector (provided by James Wang)
was constructed by combining fragments 1 and 4 from a
HaeII digest of pBR322 and represents pBR322 with base
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pairs 235 through 2351 deleted. The orientation of all inserts
is the same and is such that transcription of the 5S RNA
genes is in the same direction as transcription of the bla gene
in the vector. Plasmid s (somatic), a representative of the
family of somatic 5S RNA genes, contains the HindlIl insert
from pXlsll (2). Plasmid o*, a representative of the family of
oocyte 5S RNA genes, contains the HindIlI insert from
pXlo31 (20). Bogenhagen and Brown (3) removed the pseu-
dogene from pXlo31 to produce pXloA3'+176. Moving the
HindIII-EcoRI insert from pXloA3'+176 into pJW1+4 pro-
duced plasmid o (oocyte). The oocyte 5S RNA gene within
ott was replaced with the somatic 5S RNA gene from pXlsll
to create a new plasmid, s--oql, identical to oW except for
single base differences at eight positions within the 5S RNA
coding sequence. Plasmid s--oP, was constructed by first
exchanging the 5' flanking sequences via the HaeIII site at
position 8 of the coding sequence and then exchanging the 3'
flanking sequences via the FokI site at position 94. Because
of the existence of numerous HaeIII sites within the plas-
mids, the interchange of sequences at the desired HaeIII site
(position 8) was accomplished as follows: plasmids o4 and s
were linearized by partial digestion with HaeIII in the
presence of 250 ,uM ethidium bromide. The linear DNAs
were electrophoretically purified and digested with HindIII
and EcoRI, respectively. Appropriate DNA fragments (the
HindIII-HaeIII fragment derived from the 5' region of o*
and the HaeIII-EcoRI fragment derived from the 3' region of
s) were electrophoretically purified and ligated into the
vector to produce an intermediate plasmid. This plasmid was
then used to switch the 3' flanking sequences via the FokI
site at position 94, yielding the switch clone s--o>o containing
a somatic 5S RNA gene precisely positioned within oocyte-
type, A+T-rich flanking sequences. The pseudogene of
s--o-fo was removed by replacing the FokI-EcoRI fragment
with the corresponding fragment from o. The resulting
plasmid, s--o, was identical to plasmid o except for single
base pair differences at eight positions within the 5S RNA
coding sequence, thus transforming an oocyte SS RNA gene
into a somatic 5S RNA gene.
Oocyte microinjection. For each sample, a total of 5 ng of
plasmid DNA in 25 nl was injected into the germinal vesicle
of each of 20 oocytes. After 5 h, 250 nCi of [a-32P]GTP was
injected into the cytoplasm of each oocyte. After overnight
incubation at 18°C, the oocytes were pooled and homoge-
nized in 400 Rl of 50 mM Tris hydrochloride (pH 7.5)-50 mM
NaCl-10 mM EDTA-0.5% sodium dodecyl sulfate-pro-
teinase K (250 pug/ml). After incubation for 1 h at 37°C, the
samples were extracted twice with an equal volume of
phenol-chloroform (1:1, vol/vol), and the nucleic acids were
precipitated with ethanol. The samples were redissolved in
20 RI of formamide and heated at 100°C for 2 min before 10
RI was loaded onto an extensively preelectrophoresed 12.5%
polyacrylamide gel containing 4 M urea and 90 mM Tris-
borate (pH 8.3)-2.5 mM EDTA. Electrophoresis was done
overnight with 90 mM Tris-borate-2.5 mM EDTA as the
running buffer. This partially denaturing gel separates the
oocyte and somatic 5S RNAs even though they are of the
same length (31). In the 4 M urea gels used in our study the
oocyte 5S RNA ran more slowly than did the somatic 5S
RNA. This was the reversed order of migration relative to
the one observed by Wakefield and Gurdon (31). The differ-
ence was probably due to the absence of a stacking gel in our
version of the 4 M urea gel system. Oocytes for
microinjection were isolated from fragments of X. laevis
ovaries by digestion with 2.5 mg of collagenase per ml in
ORII buffer (83 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 1 mM
NaH2PO4, 5 mM sodium-N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid [HEPES] [pH 7.6]). After extensive
washing with ORII, the oocytes were transferred to MBS-H
buffer [88 mM NaCl, 1 mM KCI, 2.4 mM NaHCO3, 0.82 mM
MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, 10 mM sodium-
HEPES (pH 7.6), 10 mg of penicillin per ml, 10 mg of
streptomycin per ml]. Subsequent microinjections and incu-
bations were done in MBS-H buffer.
Transcription in the oocyte nuclear extract. The oocyte
nuclear extract was prepared by the method of Birkenmeier
et al. in J buffer with 1% PVP-360 (Sigma Chemical Co.)
starting with stage 5 and 6 oocytes (2). Nine microliters of
oocyte nuclear extract, corresponding to approximately nine
manually isolated germinal vesicles, was mixed with 5 ,ul of
30 mM sodium-HEPES (pH 7.6)-70 mM KCl-14 mM
MgC12-2 mM dithiothreitol-20 ,uM ZnCl2 containing 100 ng
of plasmid DNA and incubated at room temperature (-22°C)
for 15 min. Next, 10 ,uCi of [a-32P]GTP and additional
nucleoside triphosphates in 5 ,ul of 30 mM sodium-HEPES
(pH 7.6)-70 mM KCl-2 mM dithiothreitol-10% glycerol
were added. The final concentrations of added nucleoside
triphosphates in the 19-pd reaction were as follows: ATP, 1
mM; CTP, 0.4 mM; UTP, 0.2 mM; and GTP, 20 puM. After
a 2-h incubation at room temperature, 2 volumes of stop
buffer (50 mM Tris hydrochloride [pH 7.5], 50 mM NaCl, 15
mM EDTA, 0.6% sodium dodecyl sulfate, 400 ,ug of protein-
ase K per ml) were added. The samples were incubated at
37°C for 1 h, extracted once with phenol-chloroform, pre-
cipitated with ethanol, dissolved in 20 pul of formamide, and
electrophoresed on a partially denaturing gel as described
above.
Transcription in the oocyte S150 extract. The S150 extract
was prepared by the method of Glikin et al. (12). This extract
was prepared with a mixture of oocytes from all stages of
development. However, the bulk of the oocytes consisted of
the larger, stage 5 and 6 oocytes. Oocyte S150 extract (20 Pld)
was mixed with 10 plI of 36 mM sodium-HEPES (pH 7.6)-84
mM KCI-21 mM MgCl2-2.4 mM dithiothreitol-24 puM
ZnClI29% glycerol containing 100 ng of plasmid DNA and
including the components listed below so that their concen-
trations in the resulting 30-,u reaction were as follows: ATP,
3 mM; creatine phosphate, 8 mM; CTP, 0.5 mM; UTP, 0.2
mM; and GTP, 20 p.M. After a 1-h incubation, 10 ,uCi of
[a-32P]GTP was added in 3 p.l of 30 mM sodium-HEPES (pH
7.6)-70 mM KCI-18 mM MgCl2-2 mM dithiothreitol-20 p.M
ZnCl2-8% glycerol. After an additional 2 h of incubation at
room temperature, 2 volumes of stop buffer were added and
the transcription products were isolated and analyzed as
described above.
DNase I footprinting. Plasmids s--o and o were digested
with EcoRI and bacterial alkaline phosphatase, labeled with
[y-32P]ATP and T4 polynucleotide kinase, and recircularized
by ligation with T4 DNA ligase at room temperature, at a
DNA concentration of 4 p.g/ml. Approximately 80% of the
plasmid DNAs in the resulting samples were in a closed
circular configuration. Transcription assay samples (40 Pld)
containing 100 ng of plasmid DNA and 20 p.l of oocyte S150
extract were prepared essentially as described above. These
samples included nucleoside triphosphates and all exoge-
nously added components necessary for transcription. After
3.5 h at room temperature, either 1.2 pug or 0.8 pug of DNase
I (DPRF grade; Worthington Diagnostics) in 10 pul of tran-
scription buffer was added. Control digestions of DNA
alone, in which transcription buffer replaced the oocyte S150
extract, were done with either 60 or 30 ng of DNase I. DNase
I digestions were done for 1 min and were stopped by the
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FIG. 1. Clones containing 5S RNA genes ofX. laevis. (A) Diagram showing the relationship between the 5S RNA genes and their flanking
sequences. The natural (wild-type) arrangements are represented by clones labeled s (somatic) and oqi (oocyte-pseudogene). The G + C-rich
sequences (43% A + T) naturally found surrounding somatic 5S RNA genes are denoted by hatched lines. The A + T-rich sequences (76%
A+T) naturally found surrounding oocyte 5S RNA genes are denoted by filled lines. The rectangles represent 5S RNA coding sequences.
Transcription occurs from left to right in all genes. Spacer DNA regions are drawn approximately to scale, relative to the length of the 5S RNA
gene (120 base pairs). For other designations, see Materials and Methods. (B) Nucleotide sequences of 5S RNA genes. The sequences of the
noncoding DNA strands are given (2, 20). Only the differences from the oocyte gene sequence are shown for the somatic and pseudogene
sequences. The positions marked by dots at the 3' end of the pseudogene are occupied by vector sequences in the plasmids described here.
The binding site of TFIIIA as defined by nuclease footprinting is indicated.
addition of 50 ,ul of 50 mM Tris hydrochloride (pH 8)-20 mM
EDTA-1% sodium dodecyl sulfate-Proteinase K (200
,ug/ml). After 1 h at 37°C, 20 ,ul of 5 M potassium acetate was
added, and the samples were extracted with chloroform,
reextracted with phenol-chloroform, and precipitated with
ethanol. Digestion with MboII and EcoRI released two
end-labeled, full-length fragments, i.e., fragments derived
from plasmids lacking double-stranded cuts by DNase I. The
DNase I digestion products of the larger full-length frag-
ment, which contained the 5S RNA coding region, were
electrophoresed in an 8.3 M urea-15% polyacrylamide-90
mM Tris-borate-
2.5 mM EDTA gel. (The smaller full-length fragmnent and its
DNase I digestion products ran off the bottom of the gel.)
Footprints of purified TFIIIA (a gift of J. Blanco) were
obtained by using labeled plasmid DNA which had previ-
ously been digested with MboII and EcoRI. Either 50 or 15
ng of DNase I was used for these digestions.
RESULTS
Transcription of 5S RNA genes. To investigate the possible
effects of flanking sequences surrounding the 5S RNA cod-
ing regions on the differential transcription of the two
families of 5S RNA genes, we constructed specific switch
DNA clones. These switch clones consisted of somatic 5S
RNA genes positioned within the A+T-rich flanking se-
quences normally present around the oocyte-type genes
(Fig. 1). For example, the pair ofDNA clones oocyte (o) and
s-*o have the same total number of base pairs, with the
sequence differences indicated in Fig. 1B, such that o
contains an oocyte 5S RNA gene, and s-*o contains a
somatic 5S RNA gene. Both genes reside within the A+T-
rich context of flanking sequences specific for the oocyte-
type gene (Fig. 1A).
These constructs were microinjected into the nuclei (ger-
minal vesicles) of Xenopus oocytes, and the purified tran-
scription products were analyzed by electrophoresis in a
partially denaturing gel (31), which separated the identically
sized oocyte and somatic 5S RNAs on the basis of slight
differences in RNA conformation arising from their few
sequence differences (Fig. 2). Microinjection of a mixture of
o (oocyte) and s (somatic) plasmids at a 4 to 1 molar ratio
into the nucleus of the oocyte demonstrated an "-10-fold"
preference for transcription of the somatic over the oocyte
5S RNA genes (Fig. 2, lane b). These results are similar to
those previously reported (7, 9). The -10-fold preference for
transcription of the somatic 5S RNA genes in oocytes is
significantly smaller than the preference characteristic of
developing embryos, which show an -50-fold preference for
transcription of somatic 5S RNA genes just after the
midblastula transition (31, 34). This transcriptional bias
further increases during development such that the bias in
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FIG. 2. Transcription products of 5S RNA genes microinjected
into X. Iaevis oocytes. The plasmid DNAs microinjected in each
case are indicated. Abbreviations: o:s 4:1, a mixture of plasmids o
and s at a 4 to 1 molar ratio; o:sO-o 4:1, plasmids o and sl-o at a 4 to
1 molar ratio. An autoradiogram of a partially denaturing gel that
separates the somatic and oocyte 5S RNAs is shown. The 5S RNAs
marked s and o have the same electrophoretic mobility in a
completely denaturing gel.
sequence was replaced by a somatic-type coding sequence,
although the triplet of bands had a larger electrophoretic
mobility (Fig. 3A, lane e). The two extra bands in lane e of
Fig. 3A that were not present in lane a were due to the
substitution of the efficient termination signal normally
found 3' to the somatic 5S RNA gene with the leaky,
oocyte-type terminator described above.
In vitro transcription in the oocyte nuclear extract resulted
in the production of -10-fold more somatic than oocyte 5S
RNAs on a per gene basis (Fig. 3A, lanes f, g, and h). These
reactions contained pairs of plasmid DNAs which differed
exclusively in their 5S RNA coding sequence. Other exper-
iments with mixtures of plasmids o and s, in which the 5S
RNA genes are surrounded by their wild-type flanking
sequences, gave similar results (data not shown). Thus, the
-10-fold-greater preference for transcription of somatic over
oocyte 5S RNA genes in the oocyte nuclear extract was not
highly dependent on the nature of the flanking sequences.
The results of experiments similar to those of lanes f, g, and
h of Fig. 3A are shown in lanes i, j, and k, except that vector
DNA was used as a competitor instead of the plasmid o,
which contains an oocyte 5S RNA gene. The total amount of
DNA was the same in all reactions and the number of
somatic 5S RNA genes was the same in the corresponding
reactions (Fig. 3A, lanes f and i, g and j, and h and k). The
amount of somatic 5S RNA synthesized was greatly reduced
in lanes f, g, and h, when oocyte 5S RNA genes were also
present, relative to that in the corresponding lanes i, j, and k
To test the effect of flanking sequences on this ratio, a
mixture of o and s--o plasmid DNAs (Fig. 1A) was
microinjected into oocytes (Fig. 2, lane d). These two clones
contain different types of 5S RNA genes but exactly the
same A+T-rich flanking sequences characteristic for the
oocyte-type genes. Thus the difference between lanes b and
d of Fig. 2 is that the G+C-rich flanking sequences of the
somatic 5S RNA gene in the experiment of lane b have been
replaced by A+T-rich flanking sequences in the experiment
of lane d. The ratio of 5S RNA transcripts in lane d of Fig. 2
shows that the microinjected somatic 5S RNA gene is still
preferentially transcribed but that switching the flanking
sequences has reduced this preference approximately three-
fold. This reduced transcriptional preference may be due in
part to inefficient termination at the 3' end of the 5S RNA
gene when A+T-rich flanking sequences are present (see
below) and to the subsequent selective degradation of the
improperly terminated 4NAs in the oocyte. Irrespective of
the explanation, the effect of switching the flanking se-
quences on the relative rates of 5S RNA gene transcription is
relatively small, at least with microinjection into oocytes.
In vitro transcription of mixtures of somatic and oocyte 5S
RNA genes in an extract prepared from isolated oocyte
nuclei (Fig. 3A) yielded results similar to those obtained in
oocyte microinjection experiments (3, 7, 33). The efficient
transcription of the 5S RNA pseudogene is shown in Fig. 3A,
lanes b and c (22). Three transcripts were produced when
plasmid o was used as the template (Fig. 3A, lane d), even
though this plasmid contained a single oocyte 5S RNA gene
(Fig. 1A). The mnultiple transcripts were produced because
the 3' flanking sequences of the X. laevis oocyte 5S RNA
gene inefficiently terminate transcription by RNA polymer-
ase III (3). The two longer transcripts in lane d of Fig. 3A
thus resulted from termination at downstream sites. A sim-
ilar triplet of bands was seen when the oocyte-type coding
A /0,o9/<,S'0IJ,V°>/.%>/,,%/./.%
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FIG. 3. In vitro transcription of 5S RNA genes in X. laevis oocyte
extracts. (A) Transcription products from a nuclear (germinal vesi-
cle) extract; (B) transcription products from an oocyte S150 extract.
For each lane, the plasmid DNAs included in the reaction are
indicated. Each reaction contained a total of 100 ng of plasmid
DNA. For example, the transcripts in lane g came from reactions
containing 93.7 ng of plasmid o and 6.3 ng of plasmid s- o so that the
total amount of DNA was 100 ng, and the molar ratio of added
plasmids was 15 to 1. Autoradiograms of partially denaturing gels
are shown.
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of Fig. 3A, when vector DNA was used as competitor. This
result was an expected one because the oocyte 5S RNA
genes present in reactions of Fig. 3A, lanes f, g, and h were
competing for components in the extract required for tran-
scription of both types of 5S RNA genes. What was unex-
pected, however, was that the relative reduction in the
transcription of somatic 5S RNA genes was larger than the
corresponding increase in the transcription of oocyte 5S
RNA genes. One interpretation of this result is that the
oocyte 5S RNA genes were competing for the binding of
transcriptional factors but were not using these factors, once
bound, as efficiently as the somatic 5S RNA genes for the
production of 5S RNAs.
Transcription of somatic 5S RNA genes was thus favored
-10-fold more than transcription of oocyte 5S RNA genes in
assays using both microinjection into oocyte nuclei and in
vitro transcription in an oocyte nuclear extract. These re-
sults are in general agreement with those previously reported
(3, 7, 9, 33). The relative transcriptional activity of the
oocyte 5S RNA genes after microinjection and in the oocyte
nuclear extract suggests that these two experimental sys-
tems resemble the unperturbed in vivo state during oogen-
esis when the endogeneous genes for both somatic and
oocyte 5S RNA are active. This is in contrast to the strong
transcriptional bias in late embryos, in which the preference
for transcription of somatic over oocyte 5S RNA genes is
greater than 100-fold (31, 34).
In vitro transcription in a whole-oocyte extract strongly
favors somatic-type 5S RNA genes. We found that an extract
derived from whole oocytes, called the oocyte S150 extract
(12), transcribed oocyte-type 5S RNA genes extremely inef-
ficiently while allowing active transcription of the somatic-
type 5S RNA genes. The preference for transcription of
somatic over oocyte 5S RNA genes was -100-fold in the
S150 extract (Fig. 3B, lanes f, g, and h). This transcriptional
preference (Fig. 3B) is an order of magnitude higher than the
bias observed either in oocyte microinjection experiments
(Fig. 2) or for an oocyte nuclear extract (Fig. 3A). The
remarkably high degree of in vitro discrimination between
somatic and oocyte 5S RNA genes in the S150 transcription
system (Fig. 3B) thus mimicked the differential expression of
these genes in vivo, either in developing normal embryos or
in syncytial embryos after the injection of cloned 5S RNA
genes (7).
Figure 3B shows the 5S RNA transcription products
obtained with the oocyte S150 extract. Compare these
transcripts with the transcripts produced in the oocyte
nuclear extract (Fig. 3A). The DNA templates added to the
reactions were identical for each lane (Fig. 3A and B). The
only essential difference between the corresponding reac-
tions for the upper and lower panels of Fig. 3 was the nature
of the extract used. For instance, reactions for lane h in Fig.
3A and B contained a 45-fold molar excess of oocyte over
somatic 5S RNA genes. With this mixture of DNAs, the
oocyte nuclear extract (Fig. 3A, lane h) produced virtually
no somatic 5S RNAs, but there were at least twice as many
somatic as oocyte 5S RNAs made in the oocyte S150 extract
from the same mixture of DNA templates (Fig. 3B, lane h).
Thus, the oocyte S150 extract showed at least a 100-fold
preference for the transcription of somatic over oocyte 5S
RNA genes.
The accurate and efficient transcription of the somatic SS
RNA genes in the S150 extract is an argument against trivial
explanations for the inactivity of the oocyte 5S RNA genes
in this in vitro system. In addition, pulse-chase experiments
directly showed that the oocyte and somatic 5S RNAs were
equally stable in the oocyte S150 extract. No degradation of
either of the newly synthesized 5S RNAs was observed
during a 2-h chase in the extract (data not shown). Thus,
differential stability cannot account for the differential accu-
mulation of the two types of 5S RNA during transcription in
the oocyte S150 extract. Furthermore, although the total
level of 5S RNA transcription was significantly reduced
when the total concentration of 5S RNA genes in the S150
extract was reduced by up to 16-fold, no change in the
-100-fold transcriptional bias was observed under these
conditions (data not shown). Thus, the highly preferential
transcription of the somatic versus oocyte 5S RNA genes in
the S150 extract was unlikely to be due to competition for a
limiting factor in the extract.
Because the pair of plasmids (o and s-+o, Fig. 1) used as
templates (Fig. 3, lanes f, g, and h) differed exclusively
within the 5S RNA coding region, we conclude that the
observed transcriptional bias was a result of sequence dif-
ferences within the coding regions of the 5S RNA genes and
was not caused solely by the flanking sequences. However,
experiments designed to examine the effect of switching the
flanking sequences showed that the transcriptional bias
favoring somatic over oocyte-type 5S RNA genes is de-
creased approximately threefold when the wild-type se-
quences normally found adjacent to the somatic-type 5S
RNA genes are replaced by the A+T-rich oocyte-type
flanking sequences (unpublished data). The effect of flanking
sequences on the transcriptional bias in the oocyte S150
extract was thus similar to that observed using microin-
jection into oocytes (Fig. 2).
The plasmid oil contains both an oocyte 5S RNA gene and
a pseudogene separated by less than 100 base pairs of DNA
(Fig. 1A). Even though the pseudogene is actively tran-
scribed, the oocyte 5S RNA gene is largely inactive in the
oocyte S150 extract (Fig. 3B, lane b). In addition, when the
oocyte 5S RNA gene is converted into the somatic 5S RNA
gene (plasmid s--o*), keeping the flanking sequences and
the pseudogene the same (Fig. 1A), both the somatic 5S
RNA gene and the pseudogene are actively transcribed (Fig.
3B, lane c). Thus, the level of transcription of two 5S RNA
genes located quite close to each other on the same plasmid
could be regulated independently. This result suggests that
the differential regulation of 5S RNA genes, in this in vitro
system, is not based on relatively large domains of chroma-
tin having either transcriptionally active or inactive config-
urations.
TFIIIA bound to both active and inactive 5S RNA genes.
We found that TFIIIA was bound to the internal control
region of an oocyte 5S RNA gene in an oocyte S150 extract
under conditions in which the somatic-type 5S RNA gene
was transcribed at least 100-fold more efficiently than its
oocyte-type counterpart. Figure 4 illustrates the DNase I
digestion patterns of internally prelabeled, closed circular
plasmids o (Fig. 4, lanes k and 1, denoted S150, o) and s-*o
(Fig. 4, lanes m and n, denoted S150, s) during incubation in
the oocyte S150 extract under transcription conditions.
Compare these digestion patterns (lanes k through n) with
those of free DNA (denoted DNA), with the TFIIIA foot-
print observed with either highly purified TFIIIA (denoted
TFIIIA) or the TFIIIA present in a fraction from a
phosphocellulose column (denoted PC). These results show
that almost all, if not all, of the 5S RNA genes of both the
somatic and oocyte types are specifically associated with
TFIIIA in the S150 extract. A 5S RNA gene transcription
complex, consisting of at least two transcription factors in
addition to TFIIIA, has a DNase I footprint distinct from
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FIG. 4. DNase I footprinting of 5S RNA genes in the oocyte S150 extract. DNase I digestion patterns of two plasmids, s-*o and o, marked
s and o, respectively, which differ only in their 5S RNA coding regions are shown. Lanes: k through n, digestion patterns of internally
prelabeled, closed circular DNAs incubated in the oocyte S150 extract under transcription conditions; c and d, i and j, o and p, and u and
v, control digestion patterns of free DNA. Lanes i, j, o, and p, represent reactions identical to those in lanes k through n except that
transcription buffer was included instead of oocyte S150 extract, and less DNase I was used. Lanes: TFIIIA, footprints observed with purified
TFIIIA. Lanes: PC, footprints observed with a TFIIIA-containing fraction obtained by phosphocellulose chromatography of the S150 extract.
Pairs of lanes differ in the amount of DNase I used. The numbers on the right of the figure refer to the 5S RNA coding region (see the legend
to Fig. 1B) as defined by the G+A markers (19).
that of TFIIIA alone (32). Under the transcription conditions
in the oocyte S150 extract, only a TFIIIA footprint was
detected (Fig. 4), presumably because only a fraction of the
input template was actually transcribed. Even though both
genes were complexed with TFIIIA in this oocyte extract,
the somatic 5S RNA genes were actively transcribed but the
oocyte 5S RNA genes were not. This implies that the
selective transcriptional inactivity of the oocyte-type 5S
RNA genes observed in this extract is not caused by the
absence of TFIIIA at the internal control regions of the
oocyte-type 5S RNA genes.
DISCUSSION
Current models for the differential regulation of 5S RNA
gene families during development are based on the premise
that the binding of TFIIIA to the internal control region of a
5S RNA gene is the critical factor in determining the
transcriptional activity of that gene (4, 7, 9, 13, 25). Because
TFIIIA is necessary for transcription, it has been assumed
that binding of TFIIIA is also sufficient for transcription,
provided that other essential components of the transcrip-
tion complex are also available. We have found this assump-
tion to be incorrect, at least for the S150 in vitro transcrip-
tion system. The fact that transcriptionally inactive oocyte
5S RNA genes can have TFIIIA bound to the internal
control region implies that the critical factor, the component
of the system which actually sets the switch, is neither
TFIIIA binding per se nor the quantitative modulation of the
amount of TFIIIA.
Our findings, however, do not define the critical factor
responsible for the high transcriptional bias in favor of the
somatic 5S RNA genes in the S150 extract. They indicate
only that it is not TFIIIA binding per se and that the
inactivity of the oocyte 5S RNA gene does not depend solely
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on the nature of the flanking sequences or on direct compe-
tition with the somatic 5S RNA genes for a limiting factor in
the extract.
The finding that an extract prepared from whole oocytes
(as opposed to a nuclear oocyte extract) should display the
pattern of regulation of 5S RNA gene expression character-
istic not of oogenesis, but of much later stages of develop-
ment, may be related to the partitioning of specific compo-
nents between the nucleus and cytoplasm of an oocyte.
Extracts made from the nuclei of oocytes do display the
pattern of 55 RNA regulation characteristic of the stage of
development represented by the oocytes. During the prepa-
ration of the S150 extract from whole oocytes, the cytoplas-
mic and nuclear components are mixed (12). This may bring
the transcription apparatus of the oocyte nucleus into con-
tact with some components which were previously seques-
tered in the cytoplasm of the oocyte and which would
normally be allowed nuclear access only at a later stage of
development.
One interesting possibility is that TFIIIA itself may be
modified in the oocyte cytoplasm such that one form of
TFIIIA, found in the oocyte nucleus, activates both somatic
and oocyte 5S RNA genes, whereas the other form, found in
embryos and in the oocyte cytoplasm, activates somatic 5S
RNA genes but not oocyte 5S RNA genes. In this case,
TFIIIA would be acting as an activator for somatic 5S RNA
genes and as either a repressor or an activator for oocyte 5S
RNA genes, depending on the state of modification of
TFIIIA. A modified TFIIIA-oocyte 5S RNA gene complex
could bind additional transcription factors or RNA polymer-
ase III relatively poorly, resulting in less-efficient transcrip-
tion. We are not aware of an experimental precedent for
such a mechanism of differential gene regulation. A partial
precedent exists for the conversion of a regulatory gene
product into a transcriptional activator by posttranslational
modification. In this case, methylation of the Ada protein of
Escherichia coli converts this protein into an activator of
transcription (30). TFIIIA modification need not be covalent
and could arise from the binding of either another protein or
a low-molecular-weight allosteric effector. A mechanistically
related possibility, equally consistent with the data, is that
some component of the transcriptional complex which inter-
acts with the TFIIIA-5 RNA gene complex is modified in
the S150 extract such that it can sense the subtle difference
between an oocyte 5S RNA gene-TFIIIA complex and a
somatic 5S RNA gene-TFIIIA complex, the difference being
due to the few nucleotide sequence divergencies between the
two genes (Fig.1B). Either TFIIIB or TFIIIC is a possible
candidate for such a component.
Kmiec et al. have recently proposed a specific model for
the differential transcription of 5S RNA genes (15). This
model involves TFIIIA-dependent transcriptional activation
of 5S RNA genes through alterations in their chromatin
structure. Our results contradict this model. Briefly, we
found that both somatic- and oocyte-type 5S RNA genes
were saturated with TFIIIA in the oocyte S150 extract (the
same extract used by Kmiec et al.), yet we observed
considerable differences in the transcriptional activities of
the two types of 5S RNA genes. Furthermore, we found that
the rate of negative supercoiling (the rate of decrease in
linking number) of the template plasmid DNAs in the course
of incubation in the oocyteS150 extract under transcription
conditions was the same for plasmids containing either
actively transcribed somatic 5S RNA genes or relatively
inactive oocyte 5S RNA genes (data not shown). These latter
experiments, however, could not rule out the possibility that
the transcriptionally active fraction of the template DNA
has an altered structure which may not be detected by
this supercoiling assay which examines the bulk of the
plasmid.
The results of measurements of the levels of TFIIIA
protein during Xenopus development (28) are not inconsis-
tent with the binding of TFIIIA to both somatic and oocyte
5S RNA genes during embryogenesis. Shortly after the
resumption of transcription that follows the complete tran-
scriptional block during the first 12 cleavage divisions, the
preference for transcription of somatic over oocyte 5S RNA
genes is -50-fold (31, 34). The degree of selective repression
of the oocyte 5S RNA genes increases in the course of
subsequent embryonic development. The degree of repres-
sion that we have observed in vitro in the oocyte S150
extract (a -100-fold greater preference for transcription of
somatic over oocyte 5S RNA genes) and that is also ob-
served by injection of DNAs into coenocytic (syncytial)
embryos (7) is similar to the level of repression observed
during embryogenesis. Because TFIIIA is bound to both
somatic and oocyte 5S RNA genes in the oocyte S150 extract
(Fig. 4), we suggest that the pathway of selective repression
of oocyte 5S RNA genes during embryogenesis may involve
a complex of a 5S RNA gene with TFIIIA. If so, contrary to
predictions of other models for the differential regulation
of these two gene families, TFIIIA would be found bound
to both oocyte and somatic 55 RNA genes in embryos after
the midblastula transition. This prediction is directly test-
able.
In adult somatic cells, the situation appears to be different.
The preference for transcription of somatic over oocyte 5S
RNA genes is at least 1,000-fold-greater in Xenopus somatic
cells (17), at least an order of magnitude greater than the
preference characteristic for the early stages of embryo-
genesis. In addition, there is not enough TFIIIA in somatic
cells to bind all of the 5S RNA genes (28). In somatic cells,
the early replication of the somatic-type genes and the late
replication of the oocyte-type genes may provide a mecha-
nism whereby limiting amounts of TFIIIA are available only
to the somatic-type genes (10, 13, 14). Thus, although the
transcriptional switch may function with TFIIIA bound to
the gene, as suggested by our findings, the sustained repres-
sion of oocyte 5S RNA genes in somatic cells may involve
chromatin structures lacking TFIIIA.
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